In the Original Investigation titled “Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma,”¹ published online February 6, 2020, a correction was made to remove mention of the Cleveland Clinic, which had been incorrectly named as the institution that conducted the Ohio Brain Tumor Study, and to replace the Cleveland Clinic with the University Hospitals of Cleveland among the institutional review boards listed in the Methods as approving the study. This article was corrected online.

中文翻译：

---

文本中机构名称错误。

在2020年2月6日在线发表的标题为“在新诊断的胶质母细胞瘤患者的分子亚组中，最大和最大的对比肿瘤切除与生存率的关联性研究” ^1中，进行了一项校正，以移除提到了克利夫兰诊所，该医院被错误地命名为进行俄亥俄州脑肿瘤研究的机构，并且在批准该研究的《方法》中列出的机构审查委员会中，将克利夫兰诊所替换为克利夫兰大学医院。本文已在线更正。